Skip to main content
. Author manuscript; available in PMC: 2022 Apr 28.
Published in final edited form as: Eur J Nutr. 2017 Aug 14;57(7):2457–2467. doi: 10.1007/s00394-017-1518-8

Table 3.

Hazard ratios of all-cause and cardiovascular mortality according to different levels of serum calcium and phosphorus among patients with coronary heart disease

Variable No. of death Person-years Hazard ratios (95% confidence intervals)
All-cause mortality Cardiovascular mortality
Total CVD Model 1a Model 2b Model 3c Model 1a Model 2b Model 3c
Calcium by quartile
 1 (<2.18 mmol/L) 125 88 3850 1.00 1.00 1.00 1.00 1.00 1.00
 2 (2.18–2.27 mmol/L) 82 58 4075 0.69 (0.52–0.91) 0.72 (0.54–0.96) 0.72 (0.54–0.96) 0.70 (0.50–0.97) 0.75 (0.53–1.05) 0.75 (0.53–1.06)
 3 (2.28–2.36 mmol/L) 39 18 3801 0.39 (0.27–0.56) 0.46 (0.32–0.67) 0.47 (0.32–0.68) 0.26 (0.16–0.44) 0.32 (0.19–0.54) 0.32 (0.19–0.54)
 4 (≥2.37 mmol/L) 49 29 3919 0.51 (0.36–0.71) 0.57 (0.40–0.82) 0.57 (0.40–0.81) 0.44 (0.29–0.67) 0.50 (0.32–0.79) 0.50 (0.32–0.79)
Ptrend <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
1 mmol/L increase in calcium (continuous variable) 295 193 15,645 0.22 (0.13–0.37) 0.27 (0.14–0.51) 0.33 (0.18–0.61) 0.19 (0.10–0.36) 0.26 (0.12–0.54) 0.30 (0.14–0.64)
Phosphorus by quartile
 1 (≤1.01 mmol/L) 71 52 3951 1.00 1.00 1.00 1.00 1.00 1.00
 2 (1.02–1.15 mmol/L) 74 46 3903 1.10 (0.79–1.52) 1.28 (0.92–1.78) 1.29 (0.93–1.80) 0.95 (0.64–1.41) 1.07 (0.71–1.61) 1.08 (0.72–1.62)
 3 (1.16–1.29 mmol/L) 72 48 3874 1.22 (0.87–1.70) 1.41 (1.00–1.98) 1.49 (1.06–2.10) 1.15 (0.77–1.72) 1.35 (0.90–2.03) 1.45 (0.96–2.19)
 4 (>1.29 mmol/L) 78 47 3916 1.59 (1.14–2.22) 1.86 (1.32–2.63) 1.86 (1.32–2.63) 1.40 (0.93–2.10) 1.62 (1.06–2.48) 1.63 (1.07–2.48)
Ptrend 0.006 <0.001 <0.001 0.091 0.018 0.013
1 mmol/L increase in phosphorus (continuous variable) 295 193 15,645 2.65 (1.75–4.00) 2.56 (1.75–3.74) 2.29 (1.58–3.33) 2.82 (1.70–4.68) 2.60 (1.65–4.08) 2.32 (1.49–3.62)
a

Adjusted for age and sex

b

Adjusted for age, sex, marriage, education, smoking, alcohol consumption, leisure-time physical activity, types of coronary heart disease, estimated glomerular filtration rate, high-density lipoprotein cholesterol, triglycerides, history of diabetes, systolic blood pressure, body mass index, use of antihypertensive drugs, use of anti-diabetic drugs, use of lowering-lipid drugs, and use of anti-platelet drugs

c

Adjusted for variables in model 2 and also for serum calcium in the analyses of serum phosphorus or serum phosphorus in the analyses of calcium